All In MedTech

Device Trial Radar · NCT02329496

REPRISE Next Generation Delivery System

REPRISE NGDS: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of LotuS™ ValvE With the Next Generation Delivery System

Last checked: Nov 19, 2026Latest source record: May 24, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

38

Actual

Start

Dec 3, 2014

Primary completion

Oct 6, 2016

Study completion Oct 19, 2017

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Dec 31, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To confirm the acute performance and safety of the Lotus™ Valve with the Next Generation Delivery System for transcatheter aortic valve replacement (TAVR) in symptomatic patients with severe calcific aortic stenosis who are considered high risk for surgical valve replacement.

Conditions

  • Aortic Stenosis

Interventions

  • Lotus Valve and LOTUS Edge Valve SystemDevice

    Transcatheter aortic valve replacement (TAVR) with the Lotus Valve System with the Next Generation Delivery System and LOTUS Edge Valve System, with either the Lotus Introducer or iSleeve Introducer Sets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical SuccessTime frame: Immediately post-procedure (patient discharged from operative room)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Prince Charles Hospital

    Chermside, Queensland, Australia

  • Monash Heart

    Clayton, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.